期刊文献+

整合素β1、FAK和pY397FAK在非小细胞肺癌组织中的表达 被引量:1

Significance and expression of Integrin β1,focal adhesion kinase(FAK) and phosphorylated focal adhesion kinase(pY397FAK) in non-small cell lung cancer
下载PDF
导出
摘要 通过检测整合素β1亚基、FAK和其磷酸化形式pY397FAK在非小细胞肺癌(non-small cell lung cancer,NSCLC)和正常支气管黏膜上皮中的表达,探讨整合素β1与FAK在NSCLC发生、浸润和转移中的作用。应用免疫组织化学方法检测整合素β1、FAK和pY397FAK在72例NSCLC、29例淋巴结转移癌和19例正常支气管黏膜上皮中的表达,并与临床病理指标结合起来进行分析。 To explore the roles of Integrin β1, FAK and its phosphorylated form, i. e. pY397FAK, in tumorigenesis, invasion and metastasis of non-small cell lung cancer (NSCLC) by detecting the expression of Integrin β1, FAK and pY397FAK in human normal bronchial epithelium, primary NSCLC and matched lymph node (LN) metastases. Using immunohistochemical method, the expression of Integrin 131, FAK and pY397FAK in 72 cancerous tissues and 29 LN metastases as well as 19 normal bronchial epithelia was measured. The relationship between Integrin β1, FAK and pY397FAK expression and clinicopathological characteristics was analyzed.
作者 聂蓉 张红萍
出处 《武汉工业学院学报》 CAS 2009年第4期138-141,共4页 Journal of Wuhan Polytechnic University
关键词 非小细胞肺癌 整合素 黏着斑激酶 non-small cell lung cancer(NSCLC) integrin focal adhesion kinase(FAK)
  • 相关文献

参考文献9

  • 1Yao E S ,Zhan G H Increasedbetal integrin , Chen Y Y, et al. is associated with decreased survival in invasive breast cancer [ J]. Cancer Res, 2007, 67: 659-664.
  • 2Hazl Ehurst L A, Argila Cos R F, Dal Tonw S. Betal integrin mediated adhesion increases bimprotein degradation and contributes to drug resistance in leukaemia cells [ J ] Br J Haematol, 2007, 136 : 269- 275.
  • 3Owens L V, Xu L, Craven R J, et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors [J]. Cancer Res, 1995, 55(13) : 2752-2755.
  • 4Rovin J D, Frierson H F, Ledinh W, et al. Expression of focal adhesion kinase in normal and pathologic human prostate tissues [ J ]. Prostate, 2002, 53(2): 124-132.
  • 5Lark A L, Livasy C A, Calvo B, et al. Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases : immunohistochemistry and real-time PCR analyses [ J]. Clin Cancer Res, 2003, 9(1): 215-222.
  • 6Matter M L, Ruoslahti E. A signaling pathway fromthe alpha5 betal and alpha (v) beta3 integrins that elevates bcl-2 transcription [ J ] . J Biol Chem, 2001 ,276: 27757-27763.
  • 7Xie B, Zhao J, Kitagawa M, et al. Focal adhesion kinase activates Statl in integrin- mediated cell migration and adhesion [ J ]. J Biol Chem, 2001,276: 19512-19523.
  • 8邵淑娟,汪洋,杨佩满.肺癌癌前病变中的分子生物学异常事件[J].癌症,2004,23(1):99-103. 被引量:7
  • 9Reck M, Gatzemeier U. Gefitinib (" Iressa" ) : a new therapy for advanced non-small-cell lung cancer [ J ] . Respir Med, 2005, 99 (3) : 298-308.

二级参考文献44

  • 1[1]Parkin DM, Pisani P, Ferlay J. Global cancer statistics [J]. C A Cancer J Clin, 1999, 49:33 - 64.
  • 2[2]Brambilla E, Gazzeri S, Lantuejoul S,et al. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1)in precursor bronchial lesions of lung cancer [J]. Clin Cancer Res, 1998, 4:1609 - 1618.
  • 3[3]Minna JD, Fong K, Zochbauer-Muller S, et al. Molecular pathogenesis of lung cancer and potential translational applications [J]. Cancer J, 2002, MayJun; 8 Suppl 1:S41 -46.
  • 4[4]Fong KM, Sekido Y, Minna JD.Molecular pathogenesis of lung cancer[J]. J Thorac Cardiovasc Surg, 1999,118: 1136- 1152.
  • 5[5]Chen JT, Ho WL, Cheng YW, et al.Detection of p53 mutations in sputum smears precedes diagnosis of non-small cell lung carcinoma [J]. Anticancer Res, 2000, 20:2687 - 2690.
  • 6[6]Gonzalez R, Silva JM, Sanchez A, et al. Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance [J]. Ann Oncol, 2000, 11: 1097- 1104.
  • 7[7]Chung GT, Sundaresan V, Hasleton P,et al. Clonal evolution of lung tumors[J]. Cancer Res, 1996, 56: 1609-1614.
  • 8[8]Nuorva K, Soini Y, Kamel D, et al.Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas [J]. Am J Pathol, 1993,142:725 - 732.
  • 9[9]Brambilla E, Gazzeri S, Lantuejoul S,et al. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1)in precursor bronchial lesions of lung cancer [J]. Clin. Cancer Res, 1998, 4:1609 - 1618.
  • 10[10]Gonzalez R, Silva JM, Sanchez A, et al. Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance [J]. Ann Oncol, 2000, 11: 1097- 1104.

共引文献6

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部